Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
Myasthenia gravis (MG) is a chronic autoimmune neuromuscular disorder causing unpredictable muscle weakness and fatigue. Research suggests that MG patients experience elevated rates of anxiety and depression compared to those ... Read More
Continuous Coverage
Fall foliage enthusiasts planning scenic autumn trips across New England, the Great Lakes, and other iconic leaf-peeping regions…
On October 1, 2026, Apple Arcade will expand its subscription catalog with five new additions, highlighted by the…
Moonwalk Biosciences closed a $70 million Series B funding round to advance its lead adipose-targeted RNA interference candidate,…
Comedian, actor, and impressionist Jay Pharoah is bringing his high-energy stand-up act to the DC Improv for a…
A study published in Nature reveals that euchromatin forms dynamic condensed domains in living human cells, regulated specifically…
Nepal Demands Climate Accountability After Devastating Himalayan Floods Nepal finds itself at ground zero of a rapidly warming…
Global Affairs
On February 11, in Itumbiara, Brazil, a local man named Thales Machado shot and killed his two sons,…
Markets And Money
Electric vehicle adoption for long-distance highway travel is accelerating as charging infrastructure expands, battery energy density improves, and…
Digital Culture
Logitech has launched the MX Keypad, a $99.99 desktop accessory featuring nine customizable full-color LCD keys designed to…
Science And Wellbeing
Organ preservation strategies for esophageal adenocarcinoma are increasingly challenging the traditional standard of immediate surgical intervention. Researchers are…
Screen And Sound
Rising London Irish rapper Kibo is shaking up the UK music scene with his debut album ‘Kwengletaria: Ragamyff’…
Fixtures And Form
Manchester United manager Michael Carrick faces mounting pressure ahead of the Manchester derby, as club legend Paul Scholes…
